Opthalmic wafer

Details Opthalmic wafer Opthalmic wafer

1983-09-02

1987-01-20

Bell, Mark L.

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

536 551, 536118, 623 6, A61F 216, C07H 504, C07H 510

Patent

active

046380566

ABSTRACT:
Damage to endothelial and epithelial cells subject to trauma can be substantially reduced by using a wafer of a viscoelastic material. This method is particularly useful when applied prior to ophthalic surgery, particularly intraocular lens implantation surgery. Lens implantation is facilitated by the compression of lens haptics by this delivery system.

REFERENCES:
patent: 4141973 (1979-02-01), Balazs
patent: 4517295 (1985-05-01), Bracke et al.
patent: 4534069 (1985-08-01), Kelman
Healon (Sodium Hyaluronate) Product Monograph, (Pharmacia Laboratories).
Chondron Product Monograph (Kaken Pharmaceutial Co., Ltd.).
Drugs in Japan, Ethical Drug Edition, p. 216, (Japan Pharmaceutical Information Center 1975) (with English Translation).

Affiliated with

Also associated with

Rating

Opthalmic wafer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Opthalmic wafer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Opthalmic wafer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2135364